Clarivate Highly Cited Research Awards 2022

22 Nov 2022

In 2022 Clarivate released its list of the Highly Cited Reachers (HCR) for the year. 

The Highly Cited Researchers list from Clarivate, publisher of Web of Science, is an annual list of the most influential researchers worldwide. Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.

It is an honour to announce that Emeritus Professor Wayne Hall was a part of the list of Highly Cited Researchers for 2022. We congratulate Wayne on his achievement as well as the other 44 HCR awards given to UQ researchers. 

As Wayne’s research is at the intersection of science, policy and history: Emeritus Professor Wayne Hall’s high-impact research has been recognised by repeated listings as a Clarivate Highly Cited Cross-Field Researcher.

The list focuses on contemporary achievement based on an analysis of papers ranked in the top 1% by citations over the previous ten years.

Since 2020, Wayne has been listed as a Clarivate Highly Cited Researcher in the category of Cross-Field for three years in a row! With an H-index of 91 and recorded 51,827 sum of times cited it’s wonderful for him to be recognised for another year.

Wayne was first identified as a Highly Cited Researcher two decades ago in the category of Social Sciences, General, shortly after he arrived at UQ.

Wayne has also been ranked 1885th in a study of 194,984 top scientists, in all fields for career impact for September 2022. The list is determined by John Ioannidis and his team at Stanford university using Scopus data from 1998-Sept 2022. The team rank authors across all scientific fields based on their ranking of a composite indicator that considers total citations, h-index, co-authorship adjusted Schreiberhm-index and number of citations to papers as single, first or last author. Out of this list, Wayne was also ranked 10th for researchers in tobacco control with the highest lifetime c-scores.

This is a recognition of Wayne’s continuing global impact and influence on debates over the best policy options in responding to potential harms from cannabis, alcohol, tobacco, opioids, and stimulants.